BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38635231)

  • 21. Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
    Krajden S; Bishai F; Huang SN; Ronald A; Harris F; Kempston J; Anderson J; Keston S
    CMAJ; 1986 Dec; 135(11):1282-5. PubMed ID: 3536053
    [No Abstract]   [Full Text] [Related]  

  • 22. HBV/HDV coinfection.
    Caredda F; Antinori S; Pastecchia C; Moroni M
    Lancet; 1987 Aug; 2(8556):455. PubMed ID: 2887756
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F.
    Casey JL; Niro GA; Engle RE; Vega A; Gomez H; McCarthy M; Watts DM; Hyams KC; Gerin JL
    J Infect Dis; 1996 Nov; 174(5):920-6. PubMed ID: 8896491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of hepatitis B and delta virus co-infection on liver disease in Mauritania: a cross sectional study.
    Lunel-Fabiani F; Mansour W; Amar AO; Aye M; Le Gal F; Malick FZ; Baïdy L; Brichler S; Veillon P; Ducancelle A; Gordien E; Rosenheim M
    J Infect; 2013 Nov; 67(5):448-57. PubMed ID: 23796871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of hepatitis D.
    Farci P; Niro GA
    Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of delta virus infection on the virologic status in Egyptian patients with chronic hepatitis B virus genotype D.
    Fouad R; Abdo M; Eldeen HG; Sabry D; Atef M; Ahmed R; Zayed N
    J Med Virol; 2016 May; 88(5):837-42. PubMed ID: 26488214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America.
    Alvarado-Mora MV; Romano CM; Gomes-Gouvêa MS; Gutierrez MF; Carrilho FJ; Pinho JR
    Infect Genet Evol; 2011 Aug; 11(6):1462-8. PubMed ID: 21645647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate immune recognition and modulation in hepatitis D virus infection.
    Jung S; Altstetter SM; Protzer U
    World J Gastroenterol; 2020 Jun; 26(21):2781-2791. PubMed ID: 32550754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine.
    Fiedler M; Lu M; Siegel F; Whipple J; Roggendorf M
    Vaccine; 2001 Sep; 19(32):4618-26. PubMed ID: 11535309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prime/boost immunization with DNA and adenoviral vectors protects from hepatitis D virus (HDV) infection after simultaneous infection with HDV and woodchuck hepatitis virus.
    Fiedler M; Kosinska A; Schumann A; Brovko O; Walker A; Lu M; Johrden L; Mayer A; Wildner O; Roggendorf M
    J Virol; 2013 Jul; 87(13):7708-16. PubMed ID: 23637419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological response to hepatitis delta virus in hepatitis D.
    DeCock KM; Govindarajan S; Redeker AG
    Lancet; 1987 Jun; 1(8547):1438. PubMed ID: 2884532
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis D virus seroprevalence in Egyptian HBsAg-positive children: a single-center study.
    Fouad HM; Ahmed A; Reyad EM; ElSadek SM; Khattab RA; El Damasy DA
    Arch Virol; 2020 Oct; 165(10):2361-2365. PubMed ID: 32743697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mathematical models of the interrelated dynamics of hepatitis D and B.
    Packer A; Forde J; Hews S; Kuang Y
    Math Biosci; 2014 Jan; 247():38-46. PubMed ID: 24513247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of HD Ag and anti HD by radioimmunoassay in acute and chronic HBV infections in Tunisia.
    Ayed K; Gorgi Y; Pichoud C; Trepo C
    Prog Clin Biol Res; 1987; 234():441-2. PubMed ID: 3628409
    [No Abstract]   [Full Text] [Related]  

  • 35. Delta infection in Yugoslavia.
    Burek V
    Prog Clin Biol Res; 1987; 234():419-21. PubMed ID: 3628401
    [No Abstract]   [Full Text] [Related]  

  • 36. Delta infection in patients and HBsAg carriers.
    Ketiladze ES; Vyazov SO; Chernovetsky MA; Mikhailov MI; Bugayeva NP; Kozlova TP
    Prog Clin Biol Res; 1987; 234():461-6. PubMed ID: 3628413
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1.
    Spaan M; Carey I; Bruce M; Shang D; Horner M; Dusheiko G; Agarwal K
    J Hepatol; 2020 Jun; 72(6):1097-1104. PubMed ID: 31981726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.
    Morsica G; Bagaglio S; Cicconi P; Capobianchi MR; Pellizzer G; Caramello P; Orani A; Moioli C; Rizzardini G; Uberti-Foppa C; Puoti M; Monforte AD;
    J Acquir Immune Defic Syndr; 2009 Aug; 51(5):574-81. PubMed ID: 19590432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis D virus infection in patients with chronic hepatitis B virus infection.
    Chuang WL; Chang WY; Lu SN; Lin ZY; Chen SC; Hsieh MY; Wang LY; Wu CC; Chang SF; Chow TY
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Feb; 3(2):121-7. PubMed ID: 3482274
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
    Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
    PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.